According to a report from a major British teaching hospital, simple, standard, 1.5 T MRI scanning (without use of an endorectal coil) does not improve preoperative staging of localized prostate cancer and should not be used in this scenario. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: MRI, pre-surgical, staging, standard | 7 Comments »
According to the abstract of a paper to be presented at the upcoming meeting of the American Society for Clinical Oncology in Chicago at the beginning of June, 24 weeks of treatment with neoadjuvant abiraterone acetate + prednisone + an LHRH agonist appears to be able to eliminate visible risk of prostate cancer in post-surgical specimens in a small percentage of men diagnosed with high-risk disease. … READ MORE …
Filed under: Diagnosis, Drugs in development, Management, Risk, Treatment, Uncategorized | Tagged: abiraterone, dutasteride, enzalutamide, leuprolide, MDV3100, neoadjuvant, pre-surgical | 6 Comments »
One’s attitude of mind is well known to affect one’s response to certain types of treatment for many different disorders. At the very simplest level, people with a “glass half full” mentality do have a tendency to recover better from their illnesses than those who see the glass as being “half empty.” … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: Management, pre-surgical, radical prostatectomy, stress | 1 Comment »
In today’s news reports we comment briefly on recent papers that deal with:
Filed under: Living with Prostate Cancer, Management, Risk, Treatment | Tagged: anticoagulant, chemotherapy, elderly, LRP, outcome, pre-surgical, radiation therapy, radical prostatectomy | 1 Comment »
